AtriCure (NASDAQ:ATRC) expects $61.3M in Q4 revenue (+16% Y/Y) with U.S. revenue of $49.5M and $11.8M in international sales.
For FY19, AtriCure sees $230.8M in revenue (consensus: $228.7M) with an adjusted EBITDA loss of $7-9M.
AtriCure projects 2020 revenue of $254-261M (up 10-13%; consensus: $257.5M) with an adjusted EBITDA loss of about $10M.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.